| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pruritus | 31 | 2023 | 366 | 7.910 |
Why?
|
| Insect Proteins | 21 | 2020 | 253 | 2.540 |
Why?
|
| Receptors, G-Protein-Coupled | 9 | 2020 | 1241 | 2.260 |
Why?
|
| Receptors, Neuropeptide | 5 | 2020 | 105 | 1.960 |
Why?
|
| Ganglia, Spinal | 4 | 2017 | 522 | 1.410 |
Why?
|
| Mast Cells | 6 | 2020 | 1435 | 1.300 |
Why?
|
| Receptors, Proteinase-Activated | 5 | 2015 | 19 | 1.290 |
Why?
|
| Cathepsins | 3 | 2015 | 242 | 1.230 |
Why?
|
| Melanophores | 6 | 2009 | 16 | 1.180 |
Why?
|
| Cysteine Proteases | 2 | 2017 | 20 | 1.180 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 11 | 2011 | 51 | 1.120 |
Why?
|
| Dermatitis, Atopic | 8 | 2023 | 708 | 1.080 |
Why?
|
| Mucuna | 3 | 2017 | 6 | 1.030 |
Why?
|
| Vasodilator Agents | 14 | 2011 | 975 | 1.010 |
Why?
|
| Insect Hormones | 9 | 1997 | 73 | 0.930 |
Why?
|
| Psychodidae | 10 | 2020 | 26 | 0.840 |
Why?
|
| Nerve Tissue Proteins | 5 | 2020 | 4413 | 0.830 |
Why?
|
| Substance P | 3 | 2017 | 334 | 0.790 |
Why?
|
| Cysteine Endopeptidases | 2 | 2017 | 546 | 0.740 |
Why?
|
| Interneurons | 2 | 2017 | 588 | 0.730 |
Why?
|
| Spinal Cord | 3 | 2019 | 1808 | 0.720 |
Why?
|
| Gastrin-Releasing Peptide | 2 | 2017 | 37 | 0.720 |
Why?
|
| Leishmaniasis | 4 | 2008 | 64 | 0.700 |
Why?
|
| Sensory Receptor Cells | 4 | 2018 | 502 | 0.690 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 3 | 2020 | 41 | 0.680 |
Why?
|
| Skin | 12 | 2022 | 4445 | 0.630 |
Why?
|
| Dermatology | 4 | 2017 | 910 | 0.620 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2017 | 98 | 0.580 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 90 | 0.570 |
Why?
|
| Diptera | 5 | 2007 | 53 | 0.550 |
Why?
|
| HeLa Cells | 7 | 2017 | 3098 | 0.540 |
Why?
|
| Eczema | 1 | 2018 | 244 | 0.530 |
Why?
|
| Basophils | 1 | 2018 | 407 | 0.510 |
Why?
|
| Trigeminal Ganglion | 1 | 2016 | 187 | 0.510 |
Why?
|
| Peripheral Nervous System | 1 | 2016 | 148 | 0.510 |
Why?
|
| Plant Proteins | 1 | 2017 | 368 | 0.500 |
Why?
|
| Receptors, Pituitary Hormone | 5 | 2002 | 29 | 0.490 |
Why?
|
| Receptor, PAR-2 | 1 | 2014 | 33 | 0.480 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 11 | 2012 | 102 | 0.470 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 467 | 0.460 |
Why?
|
| Dynorphins | 1 | 2014 | 82 | 0.460 |
Why?
|
| Salivary Glands | 7 | 2009 | 229 | 0.450 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 90 | 0.450 |
Why?
|
| Arginine | 1 | 2017 | 934 | 0.440 |
Why?
|
| Leishmaniasis, Cutaneous | 4 | 2017 | 125 | 0.440 |
Why?
|
| Glutamic Acid | 1 | 2017 | 1162 | 0.390 |
Why?
|
| Ficain | 1 | 2010 | 2 | 0.370 |
Why?
|
| Bromelains | 1 | 2010 | 8 | 0.370 |
Why?
|
| Nitric Oxide Synthase | 3 | 2017 | 909 | 0.370 |
Why?
|
| Papain | 1 | 2010 | 64 | 0.370 |
Why?
|
| Signal Transduction | 11 | 2023 | 23278 | 0.360 |
Why?
|
| Hypersensitivity | 2 | 2017 | 1154 | 0.350 |
Why?
|
| Neural Inhibition | 1 | 2014 | 588 | 0.350 |
Why?
|
| Nitric Oxide | 4 | 2017 | 2113 | 0.350 |
Why?
|
| Skin Diseases | 5 | 2022 | 1090 | 0.340 |
Why?
|
| Animals | 62 | 2022 | 167149 | 0.320 |
Why?
|
| Skin Physiological Phenomena | 3 | 2017 | 188 | 0.310 |
Why?
|
| Cell Degranulation | 3 | 2020 | 280 | 0.310 |
Why?
|
| Salivary Proteins and Peptides | 2 | 2020 | 48 | 0.290 |
Why?
|
| Vasodilation | 5 | 2011 | 963 | 0.290 |
Why?
|
| Wound Healing | 1 | 2018 | 2782 | 0.270 |
Why?
|
| TRPM Cation Channels | 1 | 2007 | 139 | 0.270 |
Why?
|
| Cyclic AMP | 10 | 2009 | 1459 | 0.270 |
Why?
|
| Melanins | 2 | 2007 | 291 | 0.270 |
Why?
|
| Enzyme Activation | 2 | 2010 | 3600 | 0.260 |
Why?
|
| Receptors, Melanocortin | 1 | 2005 | 24 | 0.260 |
Why?
|
| Cytokines | 4 | 2023 | 7263 | 0.250 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4233 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2447 | 0.250 |
Why?
|
| Langerhans Cells | 4 | 2004 | 171 | 0.250 |
Why?
|
| Neurons | 7 | 2019 | 9384 | 0.250 |
Why?
|
| Keratinocytes | 5 | 2016 | 789 | 0.240 |
Why?
|
| Pain | 3 | 2023 | 4999 | 0.230 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide | 6 | 2012 | 12 | 0.230 |
Why?
|
| Insect Vectors | 3 | 2017 | 131 | 0.230 |
Why?
|
| Recombinant Proteins | 10 | 2013 | 6529 | 0.230 |
Why?
|
| Peptide Library | 1 | 2005 | 347 | 0.230 |
Why?
|
| Neuropeptides | 5 | 2003 | 942 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2015 | 12753 | 0.200 |
Why?
|
| Melanocytes | 2 | 2007 | 511 | 0.200 |
Why?
|
| Humans | 65 | 2023 | 755533 | 0.200 |
Why?
|
| Ice | 1 | 2022 | 102 | 0.190 |
Why?
|
| Neurotransmitter Agents | 3 | 2011 | 655 | 0.190 |
Why?
|
| Zebrafish Proteins | 1 | 2007 | 1003 | 0.190 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 13434 | 0.190 |
Why?
|
| Insect Bites and Stings | 1 | 2020 | 70 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2005 | 1186 | 0.170 |
Why?
|
| Pemphigus | 1 | 2020 | 115 | 0.170 |
Why?
|
| Capsaicin | 2 | 2017 | 231 | 0.160 |
Why?
|
| Xenopus laevis | 5 | 2009 | 962 | 0.160 |
Why?
|
| Brain | 5 | 2016 | 26737 | 0.160 |
Why?
|
| DNA, Single-Stranded | 1 | 2020 | 358 | 0.160 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2017 | 898 | 0.160 |
Why?
|
| Leishmania braziliensis | 2 | 1994 | 14 | 0.140 |
Why?
|
| Foundations | 1 | 2017 | 96 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2020 | 589 | 0.140 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2000 | 635 | 0.140 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2000 | 244 | 0.140 |
Why?
|
| Synaptic Transmission | 2 | 2015 | 1173 | 0.140 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2017 | 130 | 0.140 |
Why?
|
| Vasoactive Intestinal Peptide | 4 | 2009 | 179 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2002 | 856 | 0.140 |
Why?
|
| Receptors, Bombesin | 1 | 2015 | 26 | 0.130 |
Why?
|
| Histamine | 1 | 2017 | 498 | 0.130 |
Why?
|
| Molecular Sequence Data | 11 | 2008 | 17611 | 0.130 |
Why?
|
| Inflammation | 4 | 2020 | 10717 | 0.130 |
Why?
|
| Skin Pigmentation | 2 | 2007 | 277 | 0.130 |
Why?
|
| Chloroquine | 1 | 2017 | 279 | 0.130 |
Why?
|
| Plant Extracts | 2 | 2010 | 495 | 0.130 |
Why?
|
| Platelet Aggregation | 2 | 2000 | 797 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 124 | 0.120 |
Why?
|
| Calcitonin Gene-Related Peptide | 5 | 1996 | 302 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2017 | 448 | 0.120 |
Why?
|
| Mice | 21 | 2020 | 80745 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2010 | 3390 | 0.120 |
Why?
|
| Rabbits | 8 | 2017 | 4768 | 0.120 |
Why?
|
| Cryotherapy | 1 | 2015 | 162 | 0.120 |
Why?
|
| Neural Crest | 1 | 1996 | 277 | 0.120 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 201 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4574 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 378 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2019 | 1067 | 0.110 |
Why?
|
| Tissue Extracts | 1 | 1993 | 141 | 0.110 |
Why?
|
| Cell Line | 5 | 2016 | 15647 | 0.110 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 3 | 2009 | 9 | 0.110 |
Why?
|
| Cells, Cultured | 7 | 2017 | 18939 | 0.110 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1856 | 0.110 |
Why?
|
| Antibodies | 3 | 2017 | 2415 | 0.110 |
Why?
|
| Nausea | 1 | 2016 | 673 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2010 | 1559 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 923 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2018 | 9180 | 0.100 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2011 | 46 | 0.100 |
Why?
|
| Allergens | 2 | 2016 | 1397 | 0.100 |
Why?
|
| Cheek | 1 | 2011 | 65 | 0.100 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2011 | 57 | 0.100 |
Why?
|
| Emollients | 1 | 2011 | 40 | 0.100 |
Why?
|
| Quality of Life | 1 | 2013 | 13201 | 0.100 |
Why?
|
| Histamine Antagonists | 1 | 2011 | 92 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2010 | 2759 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 3728 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15651 | 0.090 |
Why?
|
| Cell Communication | 1 | 2018 | 1635 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 1996 | 1026 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 619 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 521 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 623 | 0.090 |
Why?
|
| Binding, Competitive | 6 | 2001 | 1142 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 8 | 2020 | 6121 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 696 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 712 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 1748 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2017 | 5417 | 0.080 |
Why?
|
| Carps | 1 | 2008 | 51 | 0.080 |
Why?
|
| Plant Structures | 1 | 2008 | 6 | 0.080 |
Why?
|
| Antipruritics | 2 | 2022 | 31 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2015 | 1332 | 0.080 |
Why?
|
| Fish Proteins | 1 | 2008 | 46 | 0.080 |
Why?
|
| Acupuncture Therapy | 1 | 2012 | 474 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2011 | 768 | 0.080 |
Why?
|
| Phenylthiourea | 1 | 2007 | 11 | 0.080 |
Why?
|
| Leg Ulcer | 1 | 1988 | 69 | 0.070 |
Why?
|
| Water Supply | 1 | 2009 | 209 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2015 | 5042 | 0.070 |
Why?
|
| Cryptococcosis | 1 | 1988 | 103 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3203 | 0.070 |
Why?
|
| Pyoderma | 1 | 1986 | 7 | 0.070 |
Why?
|
| Pituitary Hormones | 1 | 2008 | 182 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2820 | 0.070 |
Why?
|
| Dermatologic Agents | 1 | 2011 | 305 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2000 | 1547 | 0.070 |
Why?
|
| Connecticut | 1 | 2007 | 366 | 0.070 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 1998 | 113 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 9484 | 0.070 |
Why?
|
| Adenosine Diphosphate | 2 | 2000 | 429 | 0.070 |
Why?
|
| Acute Disease | 1 | 2016 | 7224 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 2008 | 4172 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 1987 | 343 | 0.060 |
Why?
|
| Mice, Inbred Strains | 4 | 2004 | 1759 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2008 | 636 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 1 | 2009 | 344 | 0.060 |
Why?
|
| Rats | 8 | 2022 | 23588 | 0.060 |
Why?
|
| Proteins | 1 | 2000 | 6029 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 10811 | 0.060 |
Why?
|
| T-Lymphocytes | 6 | 1996 | 10057 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1229 | 0.060 |
Why?
|
| Leishmaniasis, Mucocutaneous | 2 | 1996 | 14 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2000 | 1708 | 0.060 |
Why?
|
| Nitroprusside | 1 | 2004 | 272 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 125 | 0.060 |
Why?
|
| Male | 26 | 2017 | 356577 | 0.060 |
Why?
|
| Transfection | 3 | 2002 | 5781 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 900 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2000 | 886 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 2755 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2014 | 2998 | 0.060 |
Why?
|
| Chromium | 1 | 2004 | 132 | 0.060 |
Why?
|
| Pigments, Biological | 1 | 2002 | 52 | 0.050 |
Why?
|
| Pyloric Antrum | 1 | 2003 | 65 | 0.050 |
Why?
|
| Cyclic GMP | 2 | 1995 | 396 | 0.050 |
Why?
|
| Epidermis | 2 | 2004 | 522 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2017 | 6066 | 0.050 |
Why?
|
| Spleen | 4 | 1996 | 2275 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 2015 | 5087 | 0.050 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2002 | 19 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 1076 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2022 | 149 | 0.050 |
Why?
|
| Receptor Cross-Talk | 1 | 2002 | 114 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 21790 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1995 | 2183 | 0.050 |
Why?
|
| Skin Tests | 2 | 2015 | 637 | 0.050 |
Why?
|
| Adolescent | 7 | 2017 | 87236 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2014 | 6533 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1868 | 0.050 |
Why?
|
| Immune System | 2 | 1998 | 795 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 351 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2002 | 145 | 0.050 |
Why?
|
| Paresthesia | 1 | 2022 | 162 | 0.050 |
Why?
|
| Glycoproteins | 2 | 2008 | 2198 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 795 | 0.050 |
Why?
|
| Ligands | 1 | 2008 | 3286 | 0.050 |
Why?
|
| Cathelicidins | 1 | 2020 | 80 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1993 | 3177 | 0.050 |
Why?
|
| Young Adult | 4 | 2017 | 58025 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 3 | 1996 | 480 | 0.040 |
Why?
|
| PC12 Cells | 2 | 1999 | 318 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1333 | 0.040 |
Why?
|
| Venules | 2 | 2011 | 164 | 0.040 |
Why?
|
| Erythema | 2 | 1992 | 261 | 0.040 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 18027 | 0.040 |
Why?
|
| Calcium | 3 | 2010 | 5706 | 0.040 |
Why?
|
| Mycoses | 2 | 1997 | 383 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 432 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 1996 | 489 | 0.040 |
Why?
|
| Female | 19 | 2017 | 387920 | 0.040 |
Why?
|
| Naloxone | 1 | 2002 | 365 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2022 | 8167 | 0.040 |
Why?
|
| Kinetics | 3 | 1999 | 6373 | 0.040 |
Why?
|
| Gene Expression | 3 | 2010 | 7587 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 1988 | 2222 | 0.040 |
Why?
|
| Pneumonia | 1 | 2010 | 2126 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1969 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2178 | 0.040 |
Why?
|
| Cell Death | 1 | 2004 | 1664 | 0.040 |
Why?
|
| Base Sequence | 5 | 2008 | 12444 | 0.040 |
Why?
|
| COS Cells | 2 | 1999 | 1132 | 0.040 |
Why?
|
| Psychophysiology | 1 | 1998 | 132 | 0.040 |
Why?
|
| HIV Infections | 2 | 2002 | 17053 | 0.040 |
Why?
|
| Trichotillomania | 1 | 2000 | 177 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2020 | 354 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 508 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2004 | 1514 | 0.040 |
Why?
|
| Protein Binding | 3 | 2000 | 9310 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 9 | 2022 | 9109 | 0.040 |
Why?
|
| Endocrine System | 1 | 1998 | 112 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 6140 | 0.040 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2017 | 16 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4114 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5783 | 0.040 |
Why?
|
| Alternaria | 1 | 1997 | 42 | 0.040 |
Why?
|
| Dermatomycoses | 1 | 1997 | 47 | 0.040 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 1996 | 42 | 0.040 |
Why?
|
| Nitrites | 1 | 2017 | 158 | 0.040 |
Why?
|
| Adrenomedullin | 1 | 1996 | 84 | 0.030 |
Why?
|
| Hippocampus | 1 | 2009 | 3724 | 0.030 |
Why?
|
| Isoantigens | 2 | 1996 | 496 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 2423 | 0.030 |
Why?
|
| Concanavalin A | 1 | 1996 | 188 | 0.030 |
Why?
|
| Leishmaniasis, Diffuse Cutaneous | 1 | 1996 | 2 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 259 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2217 | 0.030 |
Why?
|
| Lung Diseases, Fungal | 1 | 1997 | 125 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 1984 | 1415 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1995 | 71 | 0.030 |
Why?
|
| Bombesin | 1 | 2015 | 35 | 0.030 |
Why?
|
| Endemic Diseases | 1 | 2017 | 186 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 598 | 0.030 |
Why?
|
| Zebrafish | 1 | 2007 | 2995 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1979 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2002 | 674 | 0.030 |
Why?
|
| Adult | 9 | 2017 | 217986 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2015 | 6237 | 0.030 |
Why?
|
| Middle Aged | 8 | 2017 | 218055 | 0.030 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1996 | 100 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 114 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 324 | 0.030 |
Why?
|
| Lipolysis | 1 | 2015 | 211 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 249 | 0.030 |
Why?
|
| Quinoxalines | 1 | 2015 | 288 | 0.030 |
Why?
|
| Disulfides | 1 | 1996 | 464 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 1649 | 0.030 |
Why?
|
| Autoimmune Diseases | 2 | 1987 | 2228 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 3686 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2013 | 240 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 2667 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 1193 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1993 | 286 | 0.030 |
Why?
|
| Genes, MHC Class II | 3 | 1982 | 443 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 465 | 0.030 |
Why?
|
| Prednisone | 2 | 1988 | 1564 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 1997 | 601 | 0.030 |
Why?
|
| Autoantibodies | 1 | 1981 | 2092 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1998 | 903 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1995 | 898 | 0.030 |
Why?
|
| Psychophysics | 1 | 2012 | 289 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1031 | 0.020 |
Why?
|
| Asthma | 1 | 2010 | 6151 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2015 | 597 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1991 | 160 | 0.020 |
Why?
|
| Amyloid | 1 | 1996 | 833 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 691 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2011 | 222 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1991 | 233 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2410 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1489 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2011 | 242 | 0.020 |
Why?
|
| Rhodamines | 1 | 2011 | 180 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 1996 | 1163 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 1993 | 177 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1997 | 734 | 0.020 |
Why?
|
| Apyrase | 1 | 1993 | 369 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 1955 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1055 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3407 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1996 | 1113 | 0.020 |
Why?
|
| Histocompatibility Antigens | 2 | 1982 | 452 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1998 | 1027 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1987 | 2476 | 0.020 |
Why?
|
| Aged | 5 | 2017 | 167376 | 0.020 |
Why?
|
| Cell Division | 2 | 1996 | 4447 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3848 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2009 | 112 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 516 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3785 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 1078 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 572 | 0.020 |
Why?
|
| Melanosomes | 1 | 2009 | 33 | 0.020 |
Why?
|
| Pyrilamine | 1 | 2009 | 13 | 0.020 |
Why?
|
| Vaccination | 1 | 2002 | 3337 | 0.020 |
Why?
|
| Nitroarginine | 1 | 2009 | 66 | 0.020 |
Why?
|
| Cell Separation | 2 | 1993 | 1720 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2015 | 953 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1993 | 707 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1994 | 1863 | 0.020 |
Why?
|
| Arsenites | 1 | 2009 | 65 | 0.020 |
Why?
|
| Reaction Time | 1 | 2015 | 2069 | 0.020 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2008 | 20 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 661 | 0.020 |
Why?
|
| Teratogens | 1 | 2009 | 117 | 0.020 |
Why?
|
| Bradykinin | 1 | 2009 | 207 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2390 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 2009 | 100 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1981 | 2140 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1793 | 0.020 |
Why?
|
| Crosses, Genetic | 4 | 1982 | 747 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 1996 | 2181 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 3847 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1543 | 0.020 |
Why?
|
| Calcinosis | 1 | 1997 | 1478 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1997 | 1501 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 250 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2008 | 779 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1987 | 1061 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1987 | 151 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1824 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 5785 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 935 | 0.020 |
Why?
|
| Binding Sites | 1 | 1995 | 6046 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 213 | 0.020 |
Why?
|
| Neutrophils | 2 | 2011 | 3735 | 0.020 |
Why?
|
| Epitopes | 3 | 1982 | 2501 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8953 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2046 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2013 | 1430 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 1544 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1096 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2002 | 3719 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 874 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 4314 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4722 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1841 | 0.020 |
Why?
|
| Cytochrome c Group | 2 | 1982 | 122 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 584 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 3468 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 1715 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2007 | 593 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1992 | 2116 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 1499 | 0.010 |
Why?
|
| United States | 2 | 2010 | 71888 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 8441 | 0.010 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 2003 | 6 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1920 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1699 | 0.010 |
Why?
|
| Ganglionic Stimulants | 1 | 2003 | 18 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2015 | 3290 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2003 | 68 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1250 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2003 | 88 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 36042 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1993 | 2500 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 222 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2003 | 90 | 0.010 |
Why?
|
| Atropine | 1 | 2003 | 241 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2000 | 4505 | 0.010 |
Why?
|
| RNA | 2 | 2008 | 2712 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1632 | 0.010 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2001 | 4 | 0.010 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2001 | 6 | 0.010 |
Why?
|
| Biopsy | 1 | 1994 | 6760 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 151 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11028 | 0.010 |
Why?
|
| Anesthesia | 1 | 2012 | 1554 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1981 | 422 | 0.010 |
Why?
|
| Oxygen | 1 | 2012 | 4175 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2012 | 8494 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1797 | 0.010 |
Why?
|
| Phylogeny | 1 | 2008 | 2757 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1986 | 2197 | 0.010 |
Why?
|
| Grooming | 1 | 2000 | 37 | 0.010 |
Why?
|
| Clone Cells | 2 | 1981 | 1653 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 873 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 12926 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2001 | 223 | 0.010 |
Why?
|
| Enteric Nervous System | 1 | 2003 | 209 | 0.010 |
Why?
|
| Neurites | 1 | 2001 | 388 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1999 | 205 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2719 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1992 | 4211 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1982 | 912 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1999 | 348 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4120 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21907 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 751 | 0.010 |
Why?
|
| Child | 3 | 2015 | 79427 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 39961 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3514 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 11312 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 7225 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2015 | 12838 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2002 | 570 | 0.010 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 1996 | 32 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2000 | 826 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1996 | 138 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1691 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1988 | 2266 | 0.010 |
Why?
|
| Trypsin | 1 | 1996 | 495 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1494 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2810 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1996 | 667 | 0.010 |
Why?
|
| Cysteine | 1 | 1999 | 887 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9372 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 500 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 58549 | 0.010 |
Why?
|
| Columbidae | 2 | 1982 | 38 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1995 | 547 | 0.010 |
Why?
|
| Infant | 1 | 1994 | 35867 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1997 | 1216 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 3966 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 1115 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 41893 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1993 | 674 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 1514 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 775 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1999 | 1241 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 1991 | 227 | 0.010 |
Why?
|
| DNA Probes | 1 | 1991 | 548 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7577 | 0.000 |
Why?
|
| Antigens, Surface | 2 | 1982 | 1607 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 29807 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14636 | 0.000 |
Why?
|
| Saliva | 1 | 1991 | 813 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1991 | 1690 | 0.000 |
Why?
|
| Radiography | 1 | 1997 | 6975 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10538 | 0.000 |
Why?
|
| Kidney | 1 | 1981 | 7009 | 0.000 |
Why?
|